| Literature DB >> 29885455 |
Qiang Fu1, Fan Yang2, Ji Zhao1, Xingxing Yang1, Tengxiao Xiang3, Guoli Huai1, Jiashu Zhang4, Liang Wei1, Shaoping Deng5, Hongji Yang6.
Abstract
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. It has been previously reported that CSN5 depletion is an effective method in human HCC. In the current study, we aimed to uncover gene signatures and key pathways during HCC. Gene expression profiles of GSE26485 were downloaded from GEO database. Totally, 101 differentially expressed genes (DEGs) were up-regulated and 146 ones were down-regulated. Biological processes (BP) and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) analysis showed that the DEGs were mainly enriched in regulation of cell growth, oxidation-reduction process, mitotic cytokinesis, negative regulation of macroautophagy, endosome organization, lysosome, biosynthesis of antibiotics, small cell lung cancer and glutathione metabolism and so on (P < 0.05). Protein-protein interaction (PPI) network, Kaplan-Meier, log-rank method, western blot, immunohistochemistry and encyclopedia of DNA elements (ENCODE) analysis showed that CSN5 depletion took effects through down-regulation of SMAD5-related pathways which include EXO1, CENPA and NCAPG, resulting in the inactivation of H3K4me3 and H3K36me3. Those genes represent the promising targets for therapeutic intervention in HCC patients. Published by Elsevier Inc.Entities:
Keywords: Bioinformatics analysis; CSN5 depletion; Differentially expressed gene; Hepatocellular carcinoma; SMAD5
Mesh:
Substances:
Year: 2018 PMID: 29885455 DOI: 10.1016/j.cellsig.2018.06.002
Source DB: PubMed Journal: Cell Signal ISSN: 0898-6568 Impact factor: 4.315